Summary of Purpose
The WAVECREST 2 trial is a prospective, multicenter, randomized, active controlled, clinical trial to evaluate the safety and effectiveness of the Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.Read More →
The following dates are available for this trial. Trial information last updated on 17 January 2018.
|28 Dec 2017||29 Sep 2017||1 Dec 2020||1 Dec 2025||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bita Najimipour